STEMPOINT CAPITAL LP - 31 Dec 2024 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares") (VTGN)

Filing Manager: STEMPOINT CAPITAL LP
Reporting Manager: StemPoint Capital LP
Security: Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares")
Symbol: VTGN
Shares outstanding: 28.4M shares
Disclosed Ownership: 2.33M shares
Ownership: 8.2%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 13:01:57 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
StemPoint Capital LP	8.2%	2.33M	2.05M	/s/ Sean C. Tan	Sean C. Tan, Authorized Signatory
StemPoint Capital Management GP LLC	8.2%	2.33M	2.05M	/s/ Sean C. Tan	Sean C. Tan, Authorized Signatory
Michelle Ross	8.2%	2.33M	2.05M	/s/ Michelle Ross	Michelle Ross